HYDROMORPH CONTIN

Identification of Hydromorph Contin

No description

Google image searchProduct monograph

Active ingredient

hydromorphone hydrochloride, 4.5 MG

DIN: 02359502

Dosage form(s): CAPSULE (SUSTAINED-RELEASE)

Route(s) of administration: ORAL

Description: CONTROLLED RELEASE CAPSULE

Schedule: Narcotic (CDSA I)

Company: PURDUE PHARMA

Date: 14-APR-2011

ATC:

• N02 — ANALGESICS (ATC, ATC/DDD, )
• N02A — OPIOIDS (ATC, ATC/DDD)
• N02AA — Natural opium alkaloids (ATC, ATC/DDD)
• N02AA03 — HYDROMORPHONE (ATC/DDD)

Reference brand drug: Dilaudid, Jurnista

Pharmaceutical standard: MFR

External Links for Hydromorph Contin

Search on Google

• Hydromorph Contin side effects
• Hydromorph Contin dosage
• hydromorphone hydrochloride side effects
• hydromorphone hydrochloride dosage

Purdue Pharma

Go to Purdue website to see drug product details. Sometimes you can find hydromorph contin photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.